Cargando…
Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial
IMPORTANCE: Proliferative verrucous leukoplakia (PVL) is an aggressive oral precancerous disease characterized by a high risk of transformation to invasive oral squamous cell carcinoma (OSCC), and no therapies have been shown to affect its natural history. A recent study of the PVL immune landscape...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654930/ https://www.ncbi.nlm.nih.gov/pubmed/37971722 http://dx.doi.org/10.1001/jamaoncol.2023.4853 |